Skip to Main Content

Paper Details

TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer.
Cancer Res
112
2018
-Specific CAR T Cells, ANTXR1, CAR T cell, CAR T cells, T cells, TEM8, TEM8 CAR, TEM8 CAR T cells, TEM8+, TEM8+ TNBC tumor cells, TEM8-positive TNBC cells, TEM8/ANTXR1-Specific CAR T Cells, TNBC, TNBC tumor, Triple-Negative Breast Cancer, Triple-negative breast cancer, breast cancer, breast cancer stem-like cells, colon tumors, endothelial cells, mammospheres, nontransduced T cells, patient, triple-negative breast cancer, tumor, tumor endothelial cells, tumors
Author NameAffiliation
Lacey E DobroleckiBaylor College of Medicine
Matthew L BakerBaylor College of Medicine
Poul H SorensenBritish Columbia Cancer Research Centre
Poul H SorensenUniversity of British Columbia
Poul H SorensenBritish Columbia Cancer Research Centre
Poul H SorensenUniversity of British Columbia
Matthew J EllisBaylor College of Medicine
Michael T LewisBaylor College of Medicine
Michael T LewisBaylor College of Medicine
Meenakshi HegdeCenter for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital
Meenakshi HegdeTexas Children's Cancer Center, Texas Children's Hospital
Nabil AhmedBaylor College of Medicine
Nabil AhmedCenter for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital
Nabil AhmedTexas Children's Cancer Center, Texas Children's Hospital
  • 1 - 14

Datasets

Release 1.2